International
The Morning Science

What science found today

‹
 

Research

Weekly weight-loss injection combo shows promise

Medical Xpress ·

Weekly weight-loss injection combo shows promise

The Brief

  • Two lower doses of CagriSema, a weekly injection combining cagrilintide and semaglutide, led to substantial weight loss in the trial.
  • The trial enrolled adults with obesity, or with overweight plus a weight-related health condition such as high blood pressure or sleep apnea.

Why it matters

The results add evidence that a weekly combination of two appetite-reducing medicines can produce substantial weight loss, which matters for readers following obesity treatment research.

Who’s affected

  • clinicians and researchers in obesity treatment
  • adults with obesity or overweight and weight-related health conditions

Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health condition such as high blood pressure or sleep apnea…

Timeline

  1. Trial results for two lower doses of CagriSema reported

  2. Medical Xpress - latest medical and health news stories

    Weekly weight-loss injection combo shows promise

How do you feel about this?

0 Comments

    Weekly weight-loss injection combo shows promise – The Morning Science